Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,572 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07222475Recruiting
Songwriting for relaxation in sickle cell teens
This trial explores whether writing calming songs can help teenagers with sickle cell disease feel more relaxed. Teens ages 11-18 who get care at a pediatric center can join.
Rochester, MinnesotaAges 11–18 - NCT07222527Recruiting
One stent versus two for gallbladder problems
This trial tests whether using one plastic stent or two is better for people with gallbladder disease who need an ERCP but can't have gallbladder surgery right away. It aims to find which approach works best to keep the bile duct open and prevent complications.
Rochester, MinnesotaAges 18–95 - NCT07223502RecruitingPhase 3
Comparing two treatments for high blood pressure and kidney disease
This trial tests if a new treatment combination (finerenone plus a water pill) works better than a standard fixed-dose combination for people with both high blood pressure and chronic kidney disease. It aims to find which option provides more clinical benefit.
Vienna, VirginiaAges 18 years+ - NCT07226856RecruitingPhase 2
New combo for advanced pancreatic cancer
This trial tests a new drug (BMS-986340) plus standard chemo for people whose pancreatic cancer has spread or come back. The goal is to see if this combination works better.
Scottsdale, ArizonaAges 18 years+ - NCT07227376Recruiting
Collecting lung sounds with Eko digital devices
This study uses a digital stethoscope to record lung sounds from patients with and without breathing problems. It aims to help doctors better identify different types of lung sounds.
Jacksonville, FloridaAges Any age - NCT07229040RecruitingPhase 2
Kidney protection during heated chemotherapy surgery for ovarian cancer
This trial tests two drugs (cilastatin and thiosulfate) to see which one better protects the kidneys during surgery that uses heated cisplatin chemotherapy directly in the abdomen. It is for women with advanced ovarian cancer whose disease is mostly in the belly.
Madrid, MadridAges 18–75 - NCT07229768RecruitingEarly Phase 1
Study of 177Lu-CTR-FAPI for advanced solid tumors
This trial tests a radioactive drug called 177Lu-CTR-FAPI for people with advanced solid tumors that have not responded to standard treatments. It targets tumors that show a specific protein (FAP) on PET scans. The study focuses on certain cancers like pancreatic, breast, and soft tissue sarcoma.
ShanghaiAges 18–85 - NCT07231068RecruitingPhase 1/Phase 2
Dositinib tablets for advanced lung cancer with EGFR mutation
This trial tests a new targeted therapy, Dositinib, for people with advanced non-small cell lung cancer that has an EGFR mutation and has stopped responding to earlier EGFR-targeted drugs. It aims to find the best dose and see how well it shrinks tumors.
BeijingAges 18–75 - NCT07231172Recruiting
Fatigue after stroke and its link to clinical factors
This study examines how fatigue affects people who have had a stroke, looking at physical and mental health factors. It may help understand why some people feel more tired than others after a stroke.
AnkaraAges 18 years+ - NCT07232017Recruiting
Intensive blood pressure management study at Cleveland Clinic
This trial tests a program to help people with high blood pressure get it under better control. If you have high blood pressure that is not well-managed, this study may offer extra support and monitoring.
Cleveland, OhioAges 18–85 - NCT07232602RecruitingPhase 1/Phase 2
New drug combinations for advanced bladder cancer
This study tests adding new treatments to a standard therapy (enfortumab vedotin and pembrolizumab) for people with advanced bladder cancer that hasn't been treated before. It aims to find out if these combinations are safe and work better.
San Francisco, CaliforniaAges 18 years+ - NCT07233161Recruiting
Modified arm therapy for early stroke recovery
This trial tests a modified version of constraint-induced movement therapy to help improve arm function in people who have had a stroke within the last 15 days. You may benefit if you have weakness in one arm and can follow simple instructions.
Barcelona, BarcelonaAges 18 years+ - NCT07234409Recruiting
Robotic partial nephrectomy for small kidney tumors
This trial compares different surgical methods for removing kidney tumors using a single-port robot. It aims to find the best approach for treating stage 1 kidney cancer.
MilanAges 18 years+ - NCT07234786Recruiting
Vaginal gel for treating and preventing vaginal infections
This trial tests a vaginal gel to treat and prevent common vaginal infections like yeast infections (VVC) and bacterial vaginosis (BV). It may help if you currently have symptoms like itching, discharge, or odor.
Quatre BornesAges 18 years+ - NCT07234968Recruiting
Stent vs no stent after bladder removal surgery
This study looks at whether leaving a small tube (ureteral stent) in place after bladder removal helps recovery. It compares people who get a stent to those who don't, focusing on problems like leaks or infections after surgery.
Philadelphia, PennsylvaniaAges 18–85 - NCT07235527Recruiting
Aflibercept biosimilar for wet age-related macular degeneration
This study tests a biosimilar version of aflibercept (a drug that blocks abnormal blood vessel growth) in people with wet age-related macular degeneration. It aims to see how well the treatment works in real life.
Istanbul, şişliAges 45–90 - NCT07236762RecruitingPhase 1
YTS109 cell therapy for severe autoimmune diseases
This trial tests a new cell therapy called YTS109 for people with severe autoimmune diseases like lupus, Sjögren's syndrome, systemic sclerosis, inflammatory myopathy, vasculitis, and antiphospholipid syndrome. It's for those whose disease hasn't improved with standard treatments.
BengbuAges 18–65 - NCT07236801RecruitingPhase 1
Cell therapy for hard-to-treat autoimmune diseases
This trial tests a new cell therapy called YTS109 for people with several autoimmune diseases that have not improved with standard medications. It aims to see if this treatment can help control the disease when other treatments have failed.
Xuzhou, JiangsuAges 18–65 - NCT07237334Recruiting
Emergency care study for older adults (GEM-U)
This study tracks health outcomes for older adults who are cared for in a special emergency unit designed for their needs. It helps researchers learn what works best for seniors who come to the emergency room with medical problems.
Limerick, MunsterAges 75 years+ - NCT07239206Recruiting
Serious game for ICU nurses on temperature management
This study tests whether a serious game (an educational game) can help critical care nurses learn more about targeted temperature management (cooling or warming the body to protect the brain) and improve their ability to notice and react to patient changes. You would play the game and take tests before and after to see if it works.
Taipei, TaipeiAges 20 years+ - NCT07239570RecruitingPhase 4
Using biomarkers to personalize kidney disease treatment
This study tests if matching treatments to your specific kidney disease markers can better protect your kidneys. It looks at how well Finerenone, Dapagliflozin, and Semaglutide work alone or in a sequence.
HerlevAges 18–75 - NCT07239713Recruiting
Comparing IV fluids for sepsis after abdominal surgery
This trial compares two types of intravenous fluids (Ringers Lactate vs. Sterofundin/Plasmalyte) to see which works better for sepsis after abdominal surgery. Sepsis is a serious infection that can affect the whole body. This study may help choose the best fluid for recovery.
Lahore, Punjab ProvinceAges 18–80 - NCT07240038Recruiting
Reducing breathing problems in NICU babies on ventilators
This study is testing a way to reduce the chance of a certain breathing problem (called NAV) in babies who need a breathing machine in the NICU. If your baby has been on the machine for two days or more, they may be able to join.
A Coruña, A CoruñaAges birth–6 months - NCT07240896RecruitingEarly Phase 1
Testing a new mRNA therapy for Wilson disease
This trial tests an experimental mRNA treatment (DSL101) for adults with Wilson disease. It's for people whose condition is stable on current therapy and who have certain genetic markers. The goal is to see if the new treatment can help the body process copper better and reduce the need for standard medicines.
Hefei, AnhuiAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,572 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.